Skip to main content

Articles

Page 52 of 60

  1. Metabolic Syndrome (MetS) results from the combined effect of environmental and genetic factors. We investigated the possible association of peroxisome proliferator-activated receptor-γ2 (PPARγ2) Pro12Ala and ...

    Authors: Angela Passaro, Edoardo Dalla Nora, Caterina Marcello, Francesca Di Vece, Mario Luca Morieri, Juana M Sanz, Cristina Bosi, Renato Fellin and Giovanni Zuliani
    Citation: Cardiovascular Diabetology 2011 10:112
    Content type: Original investigation Published on:

  2. In the general population, peripheral metabolic complications (MC) increase the risk for left ventricular dysfunction. Human immunodeficiency virus infection (HIV) and combination anti-retroviral therapy (cART...

    Authors: W Todd Cade, Dominic N Reeds, E Turner Overton, Pilar Herrero, Alan D Waggoner, Victor G Davila-Roman, Sherry Lassa-Claxton, Robert J Gropler, Pablo F Soto, Melissa J Krauss, Kevin E Yarasheski and Linda R Peterson
    Citation: Cardiovascular Diabetology 2011 10:111
    Content type: Original investigation Published on:

  3. Increased IL-18 serum levels have been associated with diabetes type 2, metabolic syndrome and the severity of atherosclerosis. The present study investigated the presence and influence of IL-18 genetic varian...

    Authors: Trine B Opstad, Alf Å Pettersen, Harald Arnesen and Ingebjørg Seljeflot
    Citation: Cardiovascular Diabetology 2011 10:110
    Content type: Original investigation Published on:

  4. To examine the effects of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on visceral fat adiposity, appetite, food preference, and biomarkers of cardiovascular system in Japanese patients with type 2...

    Authors: Kana Inoue, Norikazu Maeda, Susumu Kashine, Yuya Fujishima, Junji Kozawa, Aki Hiuge-Shimizu, Kohei Okita, Akihisa Imagawa, Tohru Funahashi and Iichiro Shimomura
    Citation: Cardiovascular Diabetology 2011 10:109
    Content type: Original investigation Published on:

  5. There is controversy about the specific pathophysiology of metabolic syndrome (MS) but several authors have argued that hyperinsulinemia is a key feature of the cluster. We aimed to assess whether the baseline...

    Authors: Ki-Chul C Sung, Mi-Hae H Seo, Eun-Jung J Rhee and Andrew M Wilson
    Citation: Cardiovascular Diabetology 2011 10:108
    Content type: Original investigation Published on:

  6. Bone marrow-derived circulating progenitor cells (BM-CPCs) in patients with coronary heart disease are impaired with respect to number and mobilization. However, it is unknown whether the mobilization of BM-CP...

    Authors: Ilkay Bozdag-Turan, R Goekmen Turan, C Hakan Turan, Sophie Ludovicy, Ibrahim Akin, Stephan Kische, Nicole S Arsoy, Henrik Schneider, Jasmin Ortak, Tim Rehders, Tina Hermann, Liliya Paranskaya, Peter Kohlschein, Manuela Bastian, A Tulga Ulus, Kurtulus Sahin…
    Citation: Cardiovascular Diabetology 2011 10:107
    Content type: Original investigation Published on:

  7. The growing prevalence rate of pediatric obesity, which is frequently accompanied by several cardiometabolic risk factors, has become a serious global health issue. To date, little is known regarding differenc...

    Authors: Mariska van Vliet, Martijn W Heymans, Inès A von Rosenstiel, Desiderius PM Brandjes, Jos H Beijnen and Michaela Diamant
    Citation: Cardiovascular Diabetology 2011 10:106
    Content type: Review Published on:

  8. Nicorandil, an anti-angina agent, reportedly improves outcomes even in angina patients with diabetes. However, the precise mechanism underlying the beneficial effect of nicorandil on diabetic patients has not ...

    Authors: Ken-ichi Serizawa, Kenji Yogo, Ken Aizawa, Yoshihito Tashiro and Nobuhiko Ishizuka
    Citation: Cardiovascular Diabetology 2011 10:105
    Content type: Original investigation Published on:

  9. Prediabetes (PreDM) in asymptomatic adults is associated with abnormal circadian blood pressure variability (abnormal CBPV).

    Authors: Sivarajan Kumarasamy, Kathirvel Gopalakrishnan, Dong Hyun Kim, Nader G Abraham, William D Johnson, Bina Joe and Alok K Gupta
    Citation: Cardiovascular Diabetology 2011 10:104
    Content type: Original investigation Published on:

  10. Adipokines contribute directly to the atherosclerotic process, connecting metabolic disorders such as obesity and diabetes to cardiovascular disease. Omentin-1 is a recently discovered novel adipokine, so data...

    Authors: Hye Jin Yoo, Soon Young Hwang, Ho Cheol Hong, Hae Yoon Choi, Sae Jeong Yang, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Kyung Mook Choi, Dong Seop Choi and Sei Hyun Baik
    Citation: Cardiovascular Diabetology 2011 10:103
    Content type: Original investigation Published on:

  11. Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events.We aimed to establish whether CVD event rates were influenc...

    Authors: Russell Scott, Mark Donoghoe, Gerald F Watts, Richard O'Brien, Christopher Pardy, Marja-Riitta Taskinen, Timothy ME Davis, Peter G Colman, Patrick Manning, Gregory Fulcher and Anthony C Keech
    Citation: Cardiovascular Diabetology 2011 10:102
    Content type: Original investigation Published on:

  12. Soluble ST2, a member of the of the Toll/IL-1 superfamily, is a novel biomarker with exceptional predictive value in heart failure and myocardial infarction- related mortality as well as in acute dyspneic stat...

    Authors: Evangelos Fousteris, Andreas Melidonis, George Panoutsopoulos, Konstantinos Tzirogiannis, Stefanos Foussas, Anastasios Theodosis-Georgilas, Stavros Tzerefos, Spiridon Matsagos, Eleni Boutati, Theofanis Economopoulos, George Dimitriadis and Sotirios Raptis
    Citation: Cardiovascular Diabetology 2011 10:101
    Content type: Original investigation Published on:

  13. Insulin resistance is accompanied by a cluster of metabolic changes, often referred to as metabolic syndrome. Metabolic syndrome is associated with an increased cardiovascular risk in patients with manifest ar...

    Authors: Sandra N Verhagen, Annemarie MJ Wassink, Yolanda van der Graaf, Petra M Gorter and Frank LJ Visseren
    Citation: Cardiovascular Diabetology 2011 10:100
    Content type: Original investigation Published on:

  14. Coronary artery disease has been linked with genotypes for haptoglobin (Hp) which modulates extracorpuscular hemoglobin. We hypothesized that the Hp genotype would predict progression of coronary artery calcif...

    Authors: Melissa Simpson, Janet K Snell-Bergeon, Gregory L Kinney, Orit Lache, Rachel Miller-Lotan, Yefim Anbinder, Marian J Rewers and Andrew P Levy
    Citation: Cardiovascular Diabetology 2011 10:99
    Content type: Original investigation Published on:

  15. The prognostic value of hemoglobin A1c (HbA1c) in coronary artery disease (CAD) remains controversial. Herein, we conducted a systematic review to quantify the association between elevated HbA1c levels and all...

    Authors: Yao Liu, Yan-min Yang, Jun Zhu, Hui-qiong Tan, Yan Liang and Jian-dong Li
    Citation: Cardiovascular Diabetology 2011 10:98
    Content type: Original investigation Published on:

  16. Numerous evidences suggest that diabetic heart is characterized by compromised ventricular contraction and prolonged relaxation attributable to multiple causative factors including calcium accumulation, oxidat...

    Authors: Vasundhara Kain, Sandeep Kumar and Sandhya L Sitasawad
    Citation: Cardiovascular Diabetology 2011 10:97
    Content type: Original investigation Published on:

  17. Both genetic and environmental factors play a role in the pathogenesis of type 2 diabetes and cardiovascular diseases. The magnitude of genetic and environmental influences may vary in different populations an...

    Authors: György Jermendy, Tamás Horváth, Levente Littvay, Rita Steinbach, Ádám L Jermendy, Ádám D Tárnoki, Dávid L Tárnoki, Júlia Métneki and János Osztovits
    Citation: Cardiovascular Diabetology 2011 10:96
    Content type: Original investigation Published on:

  18. Diabetes mellitus and renal dysfunction are prognostic factors after acute myocardial infarction (AMI). However, few studies have assessed the effects of renal insufficiency in association with diabetes in the...

    Authors: Chang Seong Kim, Joon Seok Choi, Jeong Woo Park, Eun Hui Bae, Seong Kwon Ma, Myung Ho Jeong, Young Jo Kim, Myeong Chan Cho, Chong Jin Kim and Soo Wan Kim
    Citation: Cardiovascular Diabetology 2011 10:95
    Content type: Original investigation Published on:

  19. Aldosterone levels are elevated in a rat model of type 2 diabetes mellitus, the Zucker Diabetic fatty rat (ZDF). Moreover blood pressure in ZDF rats is salt-sensitive. The aim of this study was to examine the ...

    Authors: Markus Resch, Peter Schmid, Kerstin Amann, Sabine Fredersdorf, Joachim Weil, Christian Schach, Christoph Birner, Daniel P Griese, Peter Kreuzer, Sabine Brunner, Andreas Luchner, Günter AJ Riegger and Dierk H Endemann
    Citation: Cardiovascular Diabetology 2011 10:94
    Content type: Original investigation Published on:

  20. The triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) has been advocated as a simple clinical indicator of insulin resistance. Thresholds of TG/HDL-C appeared to depend on ethnicity. Howeve...

    Authors: Jui-Kun Chiang, Ning-Sheng Lai, Jiunn-Kae Chang and Malcolm Koo
    Citation: Cardiovascular Diabetology 2011 10:93
    Content type: Original investigation Published on:

  21. Diabetic cardiomyopathy (CMP) is a common and disabling disease in diabetic patients, however no effective treatments have been developed. Although granulocyte-colony stimulating factor (G-CSF) improves heart ...

    Authors: Young-Hyo Lim, Jun-Ho Joe, Ki-Seok Jang, Yi-Sun Song, Byung-Im So, Cheng-Hu Fang, Jinho Shin, Jung-Hyun Kim, Heon-Kil Lim and Kyung-Soo Kim
    Citation: Cardiovascular Diabetology 2011 10:92
    Content type: Original investigation Published on:

  22. Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear. We examine...

    Authors: Britt Falskov, Thomas Steffen Hermann, Jakob Raunsø, Buris Christiansen, Christian Rask-Madsen, Atheline Major-Pedersen, Lars Køber, Christian Torp-Pedersen and Helena Dominguez
    Citation: Cardiovascular Diabetology 2011 10:91
    Content type: Original investigation Published on:

  23. Cardiovascular disease morbidity-mortality is greater in people with type 2 diabetes mellitus or metabolic syndrome. The purpose of this study was to evaluate the yearly evolution of organ damage markers in di...

    Authors: Manuel A Gomez-Marcos, Jose I Recio-Rodríguez, Maria C Patino-Alonso, Cristina Agudo-Conde, Leticia Gomez-Sanchez, Emiliano Rodriguez-Sanchez, Marta Gomez-Sanchez and Luis Garcia-Ortiz
    Citation: Cardiovascular Diabetology 2011 10:90
    Content type: Original investigation Published on:

  24. B3 adrenoreceptors (ADRB3) are abundant in adipose tissue and play the role in its metabolism and lipolysis. Some variants of the ADRB3 gene may predispose subjects for the development obesity and metabolic ab...

    Authors: Aibek E Mirrakhimov, Alina S Kerimkulova, Olga S Lunegova, Cholpon B Moldokeeva, Yulia V Zalesskaya, Samai S Abilova, Nurmira A Sovhozova, Almaz A Aldashev and Erkin M Mirrakhimov
    Citation: Cardiovascular Diabetology 2011 10:89
    Content type: Original investigation Published on:

  25. Carotid intima-media thickness (IMT), indices of large artery stiffness and measures of endothelium function may be used as markers of early atherosclerosis in type 1 diabetes mellitus (T1DM). The aim of the p...

    Authors: Carlo Palombo, Michaela Kozakova, Carmela Morizzo, Laura Gnesi, Maria Chiara Barsotti, Paolo Spontoni, Francesco Massart, Paolo Salvi, Alberto Balbarini, Giuseppe Saggese, Rossella Di Stefano and Giovanni Federico
    Citation: Cardiovascular Diabetology 2011 10:88
    Content type: Original investigation Published on:

  26. Growing evidence suggests that epicardial adipose tissue (EAT) may play a key role in the pathogenesis and development of coronary artery disease (CAD) by producing several inflammatory adipokines. Chemerin, a...

    Authors: Xiuying Gao, Shuhua Mi, Fuzhuang Zhang, Fengying Gong, Yongqiang Lai, Feng Gao, Xiaoxia Zhang, Linjie Wang and Hong Tao
    Citation: Cardiovascular Diabetology 2011 10:87
    Content type: Original investigation Published on:

  27. We analyzed the effects of insulin therapy, age and gender on the risk of ischemic heart disease (IHD) and cerebrovascular accident (CVA) according to glycemic control.

    Authors: Toshio Hayashi, Seinosuke Kawashima, Hideki Nomura, Hideki Itoh, Hiroshi Watanabe, Takashi Ohrui, Koutaro Yokote, Hirohito Sone, Yoshiyuki Hattori, Masao Yoshizumi, Koichiro Ina and Kiyoshi Kubota
    Citation: Cardiovascular Diabetology 2011 10:86
    Content type: Original investigation Published on:

  28. Progressive remodeling after myocardial infarction (MI) is a leading cause of morbidity and mortality. Recently, glucagon-like peptide (GLP)-1 was shown to have cardioprotective effects, but treatment with GLP...

    Authors: Meimei Yin, Herman HW Silljé, Maxi Meissner, Wiek H van Gilst and Rudolf A de Boer
    Citation: Cardiovascular Diabetology 2011 10:85
    Content type: Original investigation Published on:

  29. Obstructive sleep apnea (OSA) is a common yet underdiagnosed condition. The aim of our study is to test whether prediabetes and type 2 diabetes are associated with obstructive sleep apnea (OSA) in extremely ob...

    Authors: Jan Magnus Fredheim, Jan Rollheim, Torbjørn Omland, Dag Hofsø, Jo Røislien, Kristian Vegsgaard and Jøran Hjelmesæth
    Citation: Cardiovascular Diabetology 2011 10:84
    Content type: Original investigation Published on:

  30. Adiponectin is an adipokine with insulin-sensitising and anti-atherogenic effects. Two receptors for adiponectin, ADIPOR1 and ADIPOR2, have been characterized that mediate effects of adiponectin in various tis...

    Authors: Niina Siitonen, Leena Pulkkinen, Jaana Lindström, Marjukka Kolehmainen, Ursula Schwab, Johan G Eriksson, Pirjo Ilanne-Parikka, Sirkka Keinänen-Kiukaanniemi, Jaakko Tuomilehto and Matti Uusitupa
    Citation: Cardiovascular Diabetology 2011 10:83
    Content type: Original investigation Published on:

  31. To investigate the effect of physician- and patient-specific feedback with benchmarking on the quality of care in adults with type 2 diabetes mellitus (T2DM).

    Authors: Frank Nobels, Noëmi Debacker, Carlos Brotons, Moses Elisaf, Michel P Hermans, Georges Michel and Erik Muls
    Citation: Cardiovascular Diabetology 2011 10:82
    Content type: Methodology Published on:

  32. Metabolic syndrome (MS) is a clustering of cardiometabolic risk factors that is considered a predictor of cardiovascular disease, type 2 diabetes and mortality. There is no consistent evidence on whether the M...

    Authors: Vicente Martínez-Vizcaino, Francisco B Ortega, Montserrat Solera-Martínez, Jonatan R Ruiz, Idoia Labayen, Diva Eensoo, Jaanus Harro, Helle-Mai Loit, Toomas Veidebaum and Michael Sjöström
    Citation: Cardiovascular Diabetology 2011 10:81
    Content type: Original investigation Published on:

  33. Type 2 diabetes and the metabolic syndrome are associated with impaired diastolic function and increased heart failure risk. Animal models and autopsy studies of diabetic patients implicate myocardial fibrosis...

    Authors: Duncan J Campbell, Jithendra B Somaratne, Alicia J Jenkins, David L Prior, Michael Yii, James F Kenny, Andrew E Newcomb, Casper G Schalkwijk, Mary J Black and Darren J Kelly
    Citation: Cardiovascular Diabetology 2011 10:80
    Content type: Original investigation Published on:

  34. Hypertension is associated with impaired glucose tolerance and insulin resistance. Medical treatment that interferes with various steps in the renin-angiotensin system improves glucose tolerance and insulin re...

    Authors: Kosuke Fukao, Kazunori Shimada, Makoto Hiki, Takashi Kiyanagi, Kuniaki Hirose, Atsumi Kume, Hiromichi Ohsaka, Rie Matsumori, Takeshi Kurata, Tetsuro Miyazaki and Hiroyuki Daida
    Citation: Cardiovascular Diabetology 2011 10:79
    Content type: Original investigation Published on:

  35. Cinnamon has been shown to delay gastric emptying of a high-carbohydrate meal and reduce postprandial glycemia in healthy adults. However, it is dietary fat which is implicated in the etiology and is associate...

    Authors: Oonagh Markey, Conor M McClean, Paul Medlow, Gareth W Davison, Tom R Trinick, Ellie Duly and Amir Shafat
    Citation: Cardiovascular Diabetology 2011 10:78
    Content type: Original investigation Published on:

  37. Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients due to accelerated atherosclerosis. Plasma osteoprotegerin (OPG) has evolved as a biomarker for CVD. We examined the relationship b...

    Authors: Mikael K Poulsen, Mads Nybo, Jordi Dahl, Susanne Hosbond, Tina S Poulsen, Allan Johansen, Poul F Høilund-Carlsen, Henning Beck-Nielsen, Lars M Rasmussen and Jan E Henriksen
    Citation: Cardiovascular Diabetology 2011 10:76
    Content type: Original investigation Published on:

  38. Diabetes mellitus is strongly associated with cardiovascular dysfunction, derived in part from impairment of sympathetic nervous system signaling. Glucose, insulin, and non-esterified fatty acids are potent st...

    Authors: James T Thackeray, Jerry Radziuk, Mary-Ellen Harper, Erik J Suuronen, Kathryn J Ascah, Rob S Beanlands and Jean N DaSilva
    Citation: Cardiovascular Diabetology 2011 10:75
    Content type: Original investigation Published on:

  39. Angiotensin II receptor blockers (ARBs), including olmesartan and candesartan, are widely used antihypertensive agents. Many clinical studies have demonstrated that ARBs have organ-protecting effects, e.g., ca...

    Authors: Yayoi Nishida, Yasuo Takahashi, Tomohiro Nakayama, Masayoshi Soma and Satoshi Asai
    Citation: Cardiovascular Diabetology 2011 10:74
    Content type: Original investigation Published on:

  40. High glucose can induce apoptosis in vascular endothelial cells, which may contribute to the development of vascular complications in diabetes. We evaluated the role of the death receptor pathway of apoptotic ...

    Authors: Shun-ichiro Kageyama, Hiroki Yokoo, Kengo Tomita, Natsuko Kageyama-Yahara, Ryo Uchimido, Naoyuki Matsuda, Seiji Yamamoto and Yuichi Hattori
    Citation: Cardiovascular Diabetology 2011 10:73
    Content type: Original investigation Published on:

  41. We aimed to investigate whether elevated serum uric acid concentrations are associated with higher risk of metabolic syndrome (MetS) and carotid atherosclerosis in patients with type 2 diabetes.

    Authors: Qin Li, Zhen Yang, Bin Lu, Jie Wen, Zi Ye, Lili Chen, Min He, Xiaoming Tao, Weiwei Zhang, Ying Huang, Zhaoyun Zhang, Shen Qu and Renming Hu
    Citation: Cardiovascular Diabetology 2011 10:72
    Content type: Original investigation Published on:

  42. Intensive multifactorial treatment aimed at cardiovascular (CV) risk factor reduction in type 2 diabetic patients with microalbuminuria can diminish fatal and non-fatal CV. Plasma N-terminal (NT)-proBNP predic...

    Authors: Henrik Reinhard, Niels Wiinberg, Peter R Hansen, Andreas Kjær, Claus L Petersen, Kaj Winther, Hans-Henrik Parving, Peter Rossing and Peter K Jacobsen
    Citation: Cardiovascular Diabetology 2011 10:71
    Content type: Original investigation Published on:

  43. Plasma osteoprotegerin (P-OPG) is an independent predictor of cardiovascular disease in diabetic and other populations. OPG is a bone-related glycopeptide produced by vascular smooth muscle cells and increased...

    Authors: Henrik Reinhard, Mads Nybo, Peter R Hansen, Niels Wiinberg, Andreas Kjær, Claus L Petersen, Kaj Winther, Hans-Henrik Parving, Lars M Rasmussen, Peter Rossing and Peter K Jacobsen
    Citation: Cardiovascular Diabetology 2011 10:70
    Content type: Original investigation Published on:

  44. Diabetic cardiomyopathy (DCM) is a disorder of the heart muscle in people with diabetes, which is characterized by both systolic and diastolic dysfunction. The effective treatment strategy for DCM has not been...

    Authors: Bingong Li, Zeqi Zheng, Yunfeng Wei, Menghong Wang, Jingtian Peng, Ting Kang, Xin Huang, Jian Xiao, Yong Li and Zhe Li
    Citation: Cardiovascular Diabetology 2011 10:69
    Content type: Original investigation Published on:

  45. High fat diet impairs nitric oxide (NO) bioavailability, and induces insulin resistance. The link between NO availability and the metabolic adaptation to a high fat diet is not well characterized. The purpose ...

    Authors: Urszula Razny, Beata Kiec-Wilk, Lukasz Wator, Anna Polus, Grzegorz Dyduch, Bogdan Solnica, Maciej Malecki, Romana Tomaszewska, John P Cooke and Aldona Dembinska-Kiec
    Citation: Cardiovascular Diabetology 2011 10:68
    Content type: Original investigation Published on:

  46. Osteoprotegerin (OPG), a soluble member of the tumor necrosis factor receptor superfamily, is linked to cardiovascular disease. Negative associations exist between circulating OPG and cardiac function. The adi...

    Authors: Weena JY Chen, Luuk J Rijzewijk, Rutger W van der Meer, Martijn W Heymans, Eelco van Duinkerken, Mark Lubberink, Adriaan A Lammertsma, Hildo J Lamb, Albert de Roos, Johannes A Romijn, Jan WA Smit, Jeroen J Bax, Mette Bjerre, Jan Frystyk, Allan Flyvbjerg and Michaela Diamant
    Citation: Cardiovascular Diabetology 2011 10:67
    Content type: Original investigation Published on:

  47. We aimed to identify predictors of anamnestic hypoglycaemia in type-2 diabetic patients on oral mono- or dual oral combination antidiabetic pharmacotherapy.

    Authors: Diethelm Tschöpe, Peter Bramlage, Christiane Binz, Michael Krekler, Tanja Plate, Evelin Deeg and Anselm K Gitt
    Citation: Cardiovascular Diabetology 2011 10:66
    Content type: Original investigation Published on:

  48. We analyzed specific effects of an add-on therapy with pioglitazone compared to metformin and their combination in patients with basal insulin treatment on biomarkers of CV risk.

    Authors: Markolf Hanefeld, Andreas Pfützner, Thomas Forst, Iris Kleine and Winfried Fuchs
    Citation: Cardiovascular Diabetology 2011 10:65
    Content type: Original investigation Published on:

  49. Diabetes mellitus (DM) is a well-established risk factor for perioperative cardiovascular morbidity and mortality in patients undergoing noncardiac surgery. However, the impact of preoperative glucose levels o...

    Authors: Murat Biteker, Akin Dayan, Mehmet M Can, Erkan İlhan, Funda S Biteker, Ahmet Tekkeşin and Dursun Duman
    Citation: Cardiovascular Diabetology 2011 10:63
    Content type: Original investigation Published on:

  50. Cardiovascular diseases (CVD) in diabetic patients have endothelial dysfunction as a key pathogenetic event. Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), plays a ...

    Authors: Giovanni Li Volti, Salvatore Salomone, Valeria Sorrenti, Andrea Mangiameli, Vincenzo Urso, Ilias Siarkos, Fabio Galvano and Federico Salamone
    Citation: Cardiovascular Diabetology 2011 10:62
    Content type: Original investigation Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840